Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ ...
Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...
The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...
It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing hypertension.
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
The FDA says administering a drug containing particulate matter may cause local irritation or swelling. If the particulates enter blood vessels, it can travel to various organs and potentially ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results